Steiner Richard C, Buchen Jack T, Phillips Evan R, Fellin Christopher R, Yuan Xiaoning, Jariwala Shailly H
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, United States of America.
Department of Physical Medicine and Rehabilitation, The Center for Rehabilitation Sciences Research, Uniformed Services University of Health Sciences, Bethesda, Maryland, United States of America.
PLoS One. 2025 Jan 10;20(1):e0317350. doi: 10.1371/journal.pone.0317350. eCollection 2025.
The extrusion bioprinting of collagen material has many applications relevant to tissue engineering and regenerative medicine. Freeform Reversible Embedding of Suspended Hydrogels (FRESH) technology is capable of 3D printing collagen material with the specifications and details needed for precise tissue guidance, a crucial requirement for effective tissue repair. While FRESH has shown repeated success and reliability for extrusion printing, the mechanical properties of completed collagen prints can be improved further by post-print crosslinking methodologies. Photoinitiator-based crosslinking methods are simple and have proven effective in strengthening protein-based materials. The ruthenium and sodium persulfate photoinitiator system (Ru(bpy)3/SPS) has been suggested as an effective crosslinking method for collagen materials. Herein, we describe the procedure our group has developed to combine extrusion-based 3D printing of type-1 collagen using FRESH technology with Ru(bpy)3/SPS photoinitiated crosslinking methods to improve the strength and stability of 3D printed collagen structures. Mechanical testing and cell biocompatibility assessments were performed to investigate the impact of Ru(bpy)3/SPS photoinitiated crosslinking and highlight the potential limitations of this method. These results demonstrate a significant improvement in the compressive strength of type-1 collagen samples as the Ru(bpy)3/SPS concentration increases. Additionally, type-1 collagen samples crosslinked with up to 1/10 mM Ru(bpy)3/SPS support PC12 cell viability over a period of 7 days. The primary limitations that were observed and described in detail in this protocol are: the FRESH slurry preparation, printing environment, extrusion printer hardware, and quality of the ruthenium reagent.
胶原蛋白材料的挤出式生物打印在组织工程和再生医学领域有许多相关应用。悬浮水凝胶的自由形式可逆嵌入(FRESH)技术能够3D打印出具有精确组织引导所需规格和细节的胶原蛋白材料,这是有效组织修复的关键要求。虽然FRESH在挤出打印方面已多次取得成功且具有可靠性,但通过打印后交联方法可进一步改善完成的胶原蛋白打印物的机械性能。基于光引发剂的交联方法简单,且已被证明在强化蛋白质基材料方面有效。钌和过硫酸钠光引发剂体系(Ru(bpy)3/SPS)已被提议作为胶原蛋白材料的一种有效交联方法。在此,我们描述了我们团队开发的一种程序,该程序将使用FRESH技术进行的基于挤出的1型胶原蛋白3D打印与Ru(bpy)3/SPS光引发交联方法相结合,以提高3D打印胶原蛋白结构的强度和稳定性。进行了力学测试和细胞生物相容性评估,以研究Ru(bpy)3/SPS光引发交联的影响,并突出该方法的潜在局限性。这些结果表明,随着Ru(bpy)3/SPS浓度的增加,1型胶原蛋白样品的抗压强度有显著提高。此外,用高达1/10 mM Ru(bpy)3/SPS交联的1型胶原蛋白样品在7天内支持PC12细胞的活力。本方案中详细观察和描述的主要局限性包括:FRESH浆料制备、打印环境、挤出打印机硬件以及钌试剂的质量。